Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral alendronate for osteoporosis in non-ambulatory children with cerebral palsy
2006-005678-36Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Improvement in bone mineral density. Started Oct 2007; status: terminated.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2006-005678-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005678-36.